Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel on 15-Epi-Lipoxin A4
NCT02626169Phase 4Withdrawn
- Sponsor
- Baylor College of Medicine
- Start
- Dec 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in coronary artery disease (CAD), sponsored by Baylor College of Medicine. Planned start Dec 2015; status: withdrawn.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02626169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02626169.